BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12077130)

  • 1. Characterization of heparanase from a rat parathyroid cell line.
    Podyma-Inoue KA; Yokote H; Sakaguchi K; Ikuta M; Yanagishita M
    J Biol Chem; 2002 Sep; 277(36):32459-65. PubMed ID: 12077130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
    Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
    J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids.
    Bai X; Bame KJ; Habuchi H; Kimata K; Esko JD
    J Biol Chem; 1997 Sep; 272(37):23172-9. PubMed ID: 9287321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HeparanaseĀ - Discovery and Targets.
    Lindahl U; Li JP
    Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of heparanases from human hepatoma and platelets.
    Pikas DS; Li JP; Vlodavsky I; Lindahl U
    J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites.
    Ding K; Sandgren S; Mani K; Belting M; Fransson LA
    J Biol Chem; 2001 Dec; 276(50):46779-91. PubMed ID: 11577085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of heparan sulfate and heparanase in neuroinflammation.
    Zhang X; Wang B; Li JP
    Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-Ī²-D-glucuronidase (heparanase).
    Gandhi NS; Freeman C; Parish CR; Mancera RL
    Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanases produce distinct populations of heparan sulfate glycosaminoglycans in Chinese hamster ovary cells.
    Bame KJ; Robson K
    J Biol Chem; 1997 Jan; 272(4):2245-51. PubMed ID: 8999930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
    Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
    J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human heparanase nuclear localization and enzymatic activity.
    Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
    Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
    Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
    J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
    Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
    J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.
    Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D
    J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.